"There is growing evidence of the value to be gained from retrospective analysis of samples collected in clinical trials. Therefore, it has become imperative to implement procedures to ensure their integrity for future use," said Dr. Elizabeth Foot, chief scientific officer, London Genetics, Ltd. "The BioStorage benchmarking symposium provided an excellent forum to share best practices and experiences with others in the biobanking community."
BioStorage Technologies has earned the reputation of being an industry leader in comprehensive sample management through ongoing innovations and by carefully listening to the needs of researchers and scientists around the world. The company is committed to not only being the global leader in comprehensive sample management, but to also being an informational resource for the global biobanking community.
About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the global leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries. The company offers more than 100,000 square feet of secure, temperature-controlled storage as well as realtime tracking of stored biological samples, and next-day retrieval and shipment of biomaterials. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.
|SOURCE BioStorage Technologies, Inc.|
Copyright©2010 PR Newswire.
All rights reserved